Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02106858
What this trial is testing

Stivarga Regulatory Post-Marketing Surveillance Study in Korea

Who this might be right for
Colorectal Neoplasms
Bayer 316
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01139346
What this trial is testing

Study of Oral Darinaparsin in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Alaunos Therapeutics 12
Not applicableStudy completedNCT04540588
What this trial is testing

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Testing effectiveness (Phase 2)Study completedNCT02499835
What this trial is testing

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
University of Wisconsin, Madison 66
Early research (Phase 1)Study completedNCT01343043
What this trial is testing

A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma

Who this might be right for
Neoplasms
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT00918489
What this trial is testing

Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)

Who this might be right for
Soft Tissue Sarcoma
Heidelberg University 40
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Not applicableUnknownNCT05107843
What this trial is testing

Integrated Clinical-radiological Analysis of Hypoxia Markers in Pediatric Osteosarcomas

Who this might be right for
Osteosarcoma in Children
University Hospital, Strasbourg, France 30
Not applicableStudy completedNCT05131815
What this trial is testing

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

Who this might be right for
CancerCancer MetastaticNeoplasms+19 more
Cedars-Sinai Medical Center 8
Not applicableStudy completedNCT01992016
What this trial is testing

A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine

Who this might be right for
Adenocarcinoma of the ProstateBone MetastasesSoft Tissue Metastases+4 more
University of Colorado, Denver 11
Early research (Phase 1)Ended earlyNCT01258634
What this trial is testing

Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

Who this might be right for
OsteosarcomaLung Metastases
University of Chicago 2
Post-approval studies (Phase 4)Enrolling By InvitationNCT03244020
What this trial is testing

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Who this might be right for
SarcomaSoft Tissue SarcomaBone Sarcoma+4 more
Massachusetts General Hospital 2,868
Early research (Phase 1)Not Yet RecruitingNCT05361954
What this trial is testing

Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors

Who this might be right for
CancerCancer of PancreasSarcoma+2 more
Sorrento Therapeutics, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00764595
What this trial is testing

Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal TumorMetastatic Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 5
Testing effectiveness (Phase 2)Study completedNCT00102531
What this trial is testing

Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung

Who this might be right for
Osteosarcoma Metastatic
Insmed Incorporated 19
Testing effectiveness (Phase 2)Study completedNCT04873375
What this trial is testing

Cemiplimab for Secondary Angiosarcomas

Who this might be right for
Secondary AngiosarcomaLocally Advanced SarcomaMetastasis
Radboud University Medical Center 18
Early research (Phase 1)Active Not RecruitingNCT05489237
What this trial is testing

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal NeoplasmsGastrointestinal Stromal Tumor (GIST)Digestive System Disease+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC 276
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)UnknownNCT01898962
What this trial is testing

Definitive Therapy for Oligometastatic Solid Malignancies

Who this might be right for
Stage IV or Recurrent Carcinoma or Sarcoma
Rocky Mountain Cancer Centers 110
Next Page